Optiver Holding’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Buy
+178
New +$9.21K ﹤0.01% 1691
2024
Q2
Sell
-483
Closed -$51.5K 960
2024
Q1
$51.5K Buy
483
+480
+16,000% +$48.4K ﹤0.01% 543
2023
Q4
$298 Buy
+3
New +$252 ﹤0.01% 478

Other funds holding MRNA

Optiver Holding's MRNA Position: Q2 2026 in Review

Optiver Holding opened a new position in Moderna (MRNA) in Q2 2026: 178 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: Optiver Holding previously reported a position in MRNA as recently as Q1 2024.

Optiver Holding first reported a position in MRNA in Q4 2023 and has held it in 3 quarters since. The position peaked at $51.5K in Q1 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Optiver Holding held 178 shares of Moderna worth $12.5K as of Q2 2026.
  • Moderna was a new Optiver Holding position in Q2 2026.
  • Moderna made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1691 holding.
  • Optiver Holding first reported a position in Moderna in Q4 2023 and has held it in 3 quarters since.
  • Optiver Holding's Moderna position peaked at $51.5K in Q1 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.